Use of respondent-driven sampling to enhance understanding of injecting networks: A study of people who inject drugs in Sydney, Australia

International Journal of Drug Policy

Volumn 22, Issue 4, 2011, Pages 267-273

  Paquette, Dana M ^a   Bryant, Joanne ^a   De Wit, John ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Hepatitis C; HIV; Injecting drug use; Respondent driven sampling; Social networks

Indexed keywords

ABORIGINE; ADULT; ARTICLE; AUSTRALIA; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; DRUG ABUSE; FEMALE; HEALTH SURVEY; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; INFORMATION PROCESSING; MALE; PRIORITY JOURNAL; RESPONDENT DRIVEN SAMPLING; SAMPLE SIZE; SAMPLING; SOCIAL NETWORK;

ADOLESCENT; ADULT; AUSTRALIA; FEMALE; HEPATITIS C; HUMANS; INTERPERSONAL RELATIONS; MALE; MASS SCREENING; MODELS, PSYCHOLOGICAL; NEEDLE SHARING; OCEANIC ANCESTRY GROUP; PATIENT SELECTION; PEER GROUP; QUESTIONNAIRES; SOCIAL ENVIRONMENT; SUBSTANCE ABUSE, INTRAVENOUS; URBAN HEALTH; YOUNG ADULT;

EID: 79960153345     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2011.03.007     Document Type: Article

References (41)

1. Abou-Saleh M.T., Foley S. Prevalence and incidence of hepatitis C in drug users: A review. Addictive Disorders and their Treatment 2008, 7:190-198.
2. Aitken C.K., Kerger M., Crofts N. Peer-delivered hepatitis c testing and counselling: A means of improving the health of injecting drug users. Drug and Alcohol Review 2002, 21:33-37.
3. Australian Government Department of Health and Ageing Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmitted Infections Strategy 2010-2013 2010, Commonwealth of Australia, Barton, ACT.
4. Australian Government Department of Health and Ageing Third National Hepatitis C Strategy 2010-2013 2010, Commonwealth of Australia, Barton, ACT.
5. Bryant J., Brener L., Hull P., Treloar C. Needle sharing in regular sexual relationships: An examination of serodiscordance, drug using practices, and the gendered character of injecting. Drug and Alcohol Dependence 2010, 107:182-187.
6. Day C., Dolan K. Correlates of hepatitis C testing among heroin injectors in Sydney. Health Promotion Journal of Australia 2006, 17:70-72.
7. Day C.A., White B., Thein H.H., Doab A., Dore G.J., Bates A., et al. Experience of hepatitis C testing among injecting drug users in Sydney, Australia. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV 2008, 20:116-123.
8. De P., Cox J., Boivin J.F., Platt R.W., Jolly A. The importance of social networks in their association to drug equipment sharing among injecting drug users: A review. Addiction 2007, 102:1730-1739.
9. Friedman S.R., Neaigus A., Jose B., Curtis R., Des Jarlais D. Networks and HIV risk: An introduction to social network analysis for harm reductionists. International Journal of Drug Policy 1998, 9:461-469.
10. Friedman S.R., Neaigus A., Jose B., Curtis R., Goldstein M., Ildefonso G., et al. Sociometric risk networks and risk for HIV infection. American Journal of Public Health 1997, 87:1289-1296.
11. Heckathorn D.D. Respondent-driven sampling. II: Deriving valid population estimates from chain-referral samples of hidden populations. Social Problems 2002, 49:11-34.
12. Heckathorn D.D. Extensions of respondent-driven sampling: Analyzing continuous variables and controlling for differential recruitment. Sociological Methodology 2007, 37:151-207.
13. Hepatitis C Trust Diagnosing viral hepatitis in the community: A 3-month pharmacy testing pilot 2010, Hepatitis C Trust, United Kingdom.
14. Iguchi M.Y., Ober A.J., Berry S.H., Fain T., Heckathorn D.D., Gorbach P.M., et al. Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent-driven sampling: Sampling methods and implications. Journal of Urban Health 2009, 86:5-31.
15. Johnston L.G., Malekinejad M., Kendall C., Iuppa I.M., Rutherford G.W. Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: Field experiences in international settings. AIDS and Behavior 2008, 12:131-141.
16. Kilmarx P.H. Global epidemiology of HIV. Current Opinion in HIV and AIDS 2009, 4:240-246.
17. Kimber J., Hickman M., Degenhardt L., Coulson T., Van Beek I. Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: Comparison of indirect prevalence estimation methods. Addiction 2008, 103:1604-1613.
18. Kottiri B.J., Friedman S.R., Neaigus A., Curtis R., Des Jarlais D.C. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes 2002, 30:95-104.
19. Latkin C., Mandell W., Vlahov D., Knowlton A., Oziemkowska M., Celentano D. Personal network characteristics as antecedents to needle-sharing and shooting gallery attendance. Social Networks 1995, 17:219-228.
20. Malekinejad M., Johnston L.G., Kendall C., Kerr L.R.F.S., Rifkin M.R., Rutherford G.W. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: A systematic review. AIDS and Behavior 2008, 12:105-130.
21. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S.A., et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet 2008, 372:1733-1745.
22. Miller M., Neaigus A. Networks, resources and risk among women who use drugs. Social Science and Medicine 2001, 52:967-978.
23. National Centre in HIV Epidemiology and Clinical Research Australian NSP Survey National Data Report 2005-2009 2010, National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney.
24. Neaigus A., Friedman S.R., Kottiri B.J., Des Jarlais D.C. HIV risk networks and HIV transmission among injecting drug use1rs. Evaluation and Program Planning 2001, 24:221-226.
25. Ouellet L.J. Cautionary comments on an ethnographic tale gone wrong. International Journal of Drug Policy 2008, 19:238-240.
26. Paquette D.M., Bryant J., de Wit J. A Respondent-Driven Sampling (RDS) Survey of people who inject drugs in South East Sydney: An assessment of RDS assumptions and requirements. Contemporary Drug Problems 2010, 37:575-598.
27. Rhodes T., Singer M., Bourgois P., Friedman S.R., Strathdee S.A. The social structural production of HIV risk among injecting drug users. Social Science and Medicine 2005, 61:1026-1044.
28. Rothenberg R.B., Potterat J.J., Woodhouse D.E., Muth S.Q., Darrow W.W., Klovdahl A.S. Social network dynamics and HIV transmission. AIDS 1998, 12:1529-1536.
29. Salganik M.J., Heckathorn D.D. Sampling and estimation in hidden populations using respondent-driven sampling. Sociological Methodology 2004, 34:193-239.
30. Santibanez S.S., Garfein R.S., Swartzendruber A., Purcell D.W., Paxton L.A., Greenberg A.E. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. Journal of Urban Health 2006, 83:86-100.
31. Scott G. " They got their program, and I got mine": A cautionary tale concerning the ethical implications of using respondent-driven sampling to study injection drug users. International Journal of Drug Policy 2008, 19:42-51.
32. Stormer A., Tun W., Guli L., Harxhi A., Bodanovskaia Z., Yakovleva A., et al. An analysis of respondent driven sampling with injection drug users (IDU) in Albania and the Russian Federation. Journal of Urban Health 2006, 83:i73-i82.
33. Strauss S.M., Munoz-Plaza C., Tiburcio N.J., Astone-Twerell J., Des Jarlais D.C., Gwadz M., et al. Barriers and facilitators to undergoing hepatitis C virus (HCV) testing through drug treatment programs. Journal of Drug Issues 2008, 38:1161-1185.
34. Suh T., Mandell W., Latkin C., Kim J. Social network characteristics and injecting HIV-risk behaviors among street injection drug users. Drug and Alcohol Dependence 1997, 47:137-143.
35. Treloar C., Newland J., Harris M., Deacon R., Maher L. A diagnosis of hepatitis C: Insights from a study on patients' experiences. Australian Family Physician 2010, 39:589-592.
36. Valente T.W., Vlahov D. Selective risk taking among needle exchange participants: Implications for supplemental interventions. American Journal of Public Health 2001, 91:406-411.
37. Wang J., Carlson R.G., Falck R.S., Siegal H.A., Rahman A., Li L. Respondent-driven sampling to recruit MDMA users: A methodological assessment. Drug and Alcohol Dependence 2005, 78:147-157.
38. Wang J., Falck R.S., Li L., Rahman A., Carlson R.G. Respondent-driven sampling in the recruitment of illicit stimulant drug users in a rural setting: Findings and technical issues. Addictive Behaviors 2007, 32:924-937.
39. Wejnert C. An empirical test of respondent-driven sampling: Point estimates, variance, degree measures, and out-of-equilibrium data. Sociological Methodology 2009, 39:73-116.
40. Wejnert C. Social network analysis with respondent-driven sampling data: A study of racial integration on campus. Social Networks 2010, 32:112-124.
41. Zaba B., Slaymaker E., Urassa M., Boerma J.T. The role of behavioral data in HIV surveillance. AIDS 2005, (Suppl. 19):S39-S52.